- Home
- NAII vs ESLA Comparison
NAII vs ESLA Comparison
Compare NAII & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAII | ESLA |
|---|---|---|
| Founded | 1980 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.2M | 48.9M |
| IPO Year | 1987 | N/A |
Fundamental Metrics
Financial Performance| Metric | NAII | ESLA |
|---|---|---|
| Price | $3.12 | $1.60 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 20.7K | ★ 158.9K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $134,440,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 19.00 | N/A |
| 52 Week Low | $2.57 | $0.73 |
| 52 Week High | $4.40 | $3.15 |
Technical Indicators
Market Signals| Indicator | NAII | ESLA |
|---|---|---|
| Relative Strength Index (RSI) | 47.25 | 41.82 |
| Support Level | $3.11 | $1.41 |
| Resistance Level | $3.33 | $1.94 |
| Average True Range (ATR) | 0.15 | 0.25 |
| MACD | -0.05 | -0.03 |
| Stochastic Oscillator | 14.60 | 22.67 |
Price Performance
Historical ComparisonAbout NAII Natural Alternatives International Inc.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.